GlassScriptPhysician profile
Frank W Harrell
NPI 1609812676
$2,563.67
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,136 · 2020: $1,173 · 2021: $254.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $303.50 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $301.76 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $292.16 | 2019-2021 | |
| Pfizer INC. | $264.98 | 2019-2021 | |
| Astellas Pharma US INC | $222.43 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $184.61 | 2020-2021 | |
| Lilly USA, LLC | $166.50 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $150.29 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.88 | 2019-2021 | |
| Glaxosmithkline, LLC. | $139.81 | 2019-2021 | |
| Allergan, INC. | $103.84 | 2019-2020 | |
| Amgen INC. | $62.35 | 2019-2020 | |
| Amarin Pharma, INC. | $55.67 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.15 | 2019-2020 | |
| Insmed, INC. | $27.86 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $26.47 | 2019 | |
| Esperion Therapeutics, INC. | $19.44 | 2020 | |
| Corcept Therapeutics | $18.53 | 2019 | |
| Ironwood Pharmaceuticals, INC | $17.85 | 2020 | |
| Flowonix Medical Incorporated | $12.59 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Harrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.